摘要
目的:对骨科医保患者适宜植入性耗材实施规范,保证患者最大的利益。方法:统计并分析本院2019年全年骨科使用植入性耗材的情况。结果:医疗总费用中进口的植入性耗材占比分别为40.9%、28.1%、46.0%、39.4%,较平均值31.2%高,国产耗材占医疗总费用的比例分别为39.4%、26.3%、31.5%。分析费用的角度,自费比例情况:进口耗材分别为46.3%、45.6%、44.3%、49.9%、46.5%;国产为30.4%。结论:经强化培训力度,采购审批严谨的程序,强化安全认证,加大监管院内的力度,将规范化管理的制度全员推行,强化耗材的管理,使患者最大的利益得到保证。
Objective:To implement specifications for the appropriate implant consumables for orthopedic medical insurance patients,so as to ensure the maximum benefit of patients.Methods:Statistics and analysis were made on the use of implant consumables in the department of orthopedics in 2019.Results:The proportion of imported implantable consumables in the total medical expenses was 40.9%,28.1%,46.0%and 39.4%,higher than the average of 31.2%.The proportion of domestic consumables in the total medical expenses was 39.4%,26.3%and 31.5%,respectively.The situation of self-expense ratio:imported consumables are 46.3%,45.6%,44.3%,49.9%and 46.5%respectively;Domestic production was 30.4%.Conclusion:Through intensive training,rigorous procedures of procurement approval,the standardized management system will be fully implemented,and the management of consumables will be strengthened,so as to ensure the maximum interests of patients.
作者
石青梅
SHI Qing-mei(Chaoyang Central Hospital,Liaoning Chaoyang 122000)
出处
《中国医疗器械信息》
2020年第24期187-188,共2页
China Medical Device Information
关键词
进口耗材
国产耗材
骨科
医保
imported consumables
domestic consumables
orthopedics
medical insurance